Physical AI News (Japan)

Physical AI, robotics and compute — reported from Japan.

日本語
· Industry· 日本語で読む

Forbes Publishes Essay on Surgical Robots

Forbes published an essay about surgical robots. Publishing an essay is different from announcing a technology demonstration or product launch. Assessing the track record of surgical robots requires checking the subjects and operating methods involved.

What happened

Forbes published an essay about surgical robots on November 19, 2026.

Analysis

This is the publication of an essay about surgical robots, not an announcement of a technology demonstration or product launch. The headline confirms only the topic; it cannot be treated as evidence of performance, applicable procedures, the stage of clinical use or regulatory approval. The essay should not be counted as a technological advance in surgical automation itself. Readers need to distinguish the issues covered by the publication from demonstrations and deployments that have actually been verified. For details on the essay’s specific content and evidence, see the original source. For comparison, we reported on Humanoid robot performs first surgery on a living subject. That report said the surgery on a living subject was performed remotely. However, the information provided does not confirm that the technology in that case is the same as the technology covered in this essay, or that the surgery was performed by an autonomous system. Remote operation and autonomous action can differ in the degree of human involvement and the scope of responsibility, so progress should not be assessed by treating them all as the same under the term “surgical robot.” Also, IDC analyzes the impact of FCC regulations covers the impact of regulations on humanoid robot revenue in the United States; it does not show the impact of regulation on medical surgical robots. There is no basis for linking the regulatory or market effects in the two fields simply because both involve robots. The next questions to check are whether the essay identifies a specific system or procedure, whether the evaluation was conducted on a living or nonliving subject, which steps were performed by humans, and which sources support claims about safety and regulatory status. Without this information, no conclusions can be drawn about the technology’s maturity or the scope of its clinical application.

Sources

Translated from the Japanese original: /news/forbes-geka-shujutsu-robotto-wo-atsukau-ronkou-wo-keisai-ca4a98. The Japanese version is authoritative if they differ.